This restructure takes place as the company celebrates 10 years in business. Originally founded in 1999 as a GMP specialist to aid regulatory compliance, GxP Consulting has now increased its capabilities and service offerings to its portfolio in a number of consulting and training areas in order to support the entire drug development cycle. This is largely part of its new focused strategy to expand services and support to customers in Europe and America, having recently opened a North American office in Irvine, California.
Under the leadership of two of the original founders, the business has grown 10 fold over its first 10 years now with a team of 40 consultants, rising from a UK-focused small business into an international organization. The company now provides a wealth of services to world-leading multinational pharmaceutical and biopharmaceutical companies across mainland Europe and America. As the company enters its second decade, the original core values remain; to listen to its clients, to understand the business drivers of its clients, to identify practical solutions to problems and to deliver these as cost-effectively and efficiently as possible.
GxP consulting has added new services to its portfolio and now offers clinical project management and technology consulting, headed by Dr Neil Rotherham, biopharmaceutical process development headed by Dr Stephen Collins and strategic planning consulting, headed by Jim Stracey.
GxP consulting is also offering extended capabilities in:
• Computer systems validation, headed by Mark Wright;
• Regulatory & validation project management headed, by Dr Tom Dine and;
• Qualified Person (QP) services, headed by Dr Anthony Gasson;
• QP services offered now include auditing / advisory services, licence application preparation through to the provision of a registered Qualified Person within a business for the purpose of product release. GxP’s QP Consultants are all registered as Qualified Person under Directive 75/319 EEC.
With many years’ experience in advising on how to best meet the regulatory requirements of the MHRA, FDA, EMEA and ICH, GxP consulting’s team is highly skilled and experienced in identifying, communicating, managing and delivering Good Manufacturing Practice (GMP), Good Automated Manufacturing Practice (GAMP), Good Clinical Practice (GCP) and Good Laboratory Practice (GLP) requirements.
There are ever increasing demands on the biopharmaceutical and pharmaceutical industries to meet increasing regulatory and legislative requirements, whilst improving the performance and efficiency of the business. With a wealth of industry knowledge GxP consulting is ideally placed to not only provide regulatory compliance services, but also to advise companies on optimal and most cost-effective solutions.
Headquartered in Nottingham, UK with offices in Irvine California, GxP consulting provides cost-effective, results-focused regulatory compliance services to the highly regulated pharmaceutical and biopharmaceutical industries. The company has expanded to support industries with ever increasing requirements of regulatory compliance, covering pre-clinical and clinical business areas within GLP and GCP.
For more information on GxP Consulting, please call +44 (0) 115 9124547 (EU) or +1 949 725 2946 (US), email info[.]gxpeu.com.
GxP Ltd. (gxpeu.com) provides businesses with cost-effective, results-focused regulatory compliance (GMP, GAMP, GLP, GEP, GCP, GxP), qualified person (QP), quality assurance (QA), consulting, project management, validation, process engineering, computer systems, laboratory equipment, project management, design studies and training services. Specializing within the Biotechnology, Pharmaceutical, Consumer Healthcare, Medical Devices and Veterinary industries, GxP Ltd. provides a range of services to meet customer’s needs.
For further press information please contact: Celine Callender, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom.